Prognostic Value of Some Biochemical Markers in Breast Cancer

Sohag University1 site in 1 country90 target enrollmentFebruary 2023

ConditionsBreast Cancer Female

Overview

Phase: Not Applicable
Intervention: Not specified
Conditions: Breast Cancer Female
Sponsor: Sohag University
Enrollment: 90
Locations: 1
Primary Endpoint: serum level of Ca15-3
Status: Not yet recruiting
Last Updated: 3 years ago

Overview Investigators Eligibility Criteria Outcomes Sites Similar Trials

Overview

Brief Summary

breast cancer is the most common type of cancer in women and first cause of cancer death among them. in Egypt it constitutes 33% of female cancer cases and more than22000 new cases diagnosed each year. there are many prognostic factors for breast cancer as Tumer size, axillary lymph node status, hormonal receptor status, and tumer markers as Ca15-3 and interferon gamma.

Registry

clinicaltrials.gov

Start Date

February 2023

End Date

December 2023

Last Updated

3 years ago

Study Type

Observational

Sex

Female

Investigators

Sponsor

Sohag University

Responsible Party

Principal Investigator

Amany Fathy Abdelrasoul

demonestrator at medical biochemistry

Sohag University

Eligibility Criteria

Inclusion Criteria

•female patients aged more than or equal 18 year diagnosed with breast cancer
•metastatic and non-metastatic cancer premenopausal and postmenopausal female positive and negative hormonal receptors and HER2 receptor taking any systemic treatment taking radiotherapy or not